Immuron Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Immuron Limited with three other
pharmaceutical manufacturers in Australasia:
Paradigm Biopharmaceuticals Ltd
sales of 2.74 million Australian Dollars [US$1.98 million]
(3.43 million Australian Dollars [US$2.48 million]
of which 100%
was Pharmaceutical Research and Development), and
(3.30 million Australian Dollars [US$2.38 million]
During the year ended June of 2018, sales at
Immuron Limited were A$3.69 million (US$2.67 million).
increase of 23.9%
versus 2017, when the company's sales were A$2.98 million.
This was the fifth consecutive year of sales increases at Immuron Limited
(and since 2013, sales have increased a total of 2,366%).